36.01
price down icon3.64%   -1.36
 
loading
Schlusskurs vom Vortag:
$37.37
Offen:
$36.55
24-Stunden-Volumen:
1.67M
Relative Volume:
0.64
Marktkapitalisierung:
$6.36B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-327.36
EPS:
-0.11
Netto-Cashflow:
$-28.11M
1W Leistung:
-10.11%
1M Leistung:
+7.91%
6M Leistung:
+12.46%
1J Leistung:
+114.86%
1-Tages-Spanne:
Value
$35.88
$37.19
1-Wochen-Bereich:
Value
$35.88
$40.99
52-Wochen-Spanne:
Value
$16.21
$46.48

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
Firmenname
Tg Therapeutics Inc
Name
Telefon
(212) 554-4484
Name
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
Mitarbeiter
352
Name
Twitter
@TGTherapeutics
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
TGTX's Discussions on Twitter

Vergleichen Sie TGTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TGTX
Tg Therapeutics Inc
36.01 6.36B 264.79M -14.36M -28.11M -0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.45 115.69B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
529.24 53.25B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
307.99 39.22B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
577.89 35.78B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
269.63 27.68B 3.81B -644.79M -669.77M -6.24

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-29 Eingeleitet TD Cowen Buy
2023-08-02 Hochstufung Goldman Sell → Neutral
2023-06-26 Fortgesetzt Jefferies Buy
2022-05-20 Eingeleitet BofA Securities Underperform
2022-02-23 Bestätigt B. Riley Securities Buy
2021-11-15 Herabstufung Goldman Neutral → Sell
2021-04-20 Eingeleitet Goldman Neutral
2021-04-19 Bestätigt H.C. Wainwright Buy
2020-09-01 Eingeleitet JP Morgan Overweight
2020-08-11 Bestätigt H.C. Wainwright Buy
2020-06-05 Eingeleitet Evercore ISI Outperform
2020-01-17 Bestätigt H.C. Wainwright Buy
2019-11-27 Fortgesetzt B. Riley FBR Buy
2019-02-06 Fortgesetzt Jefferies Buy
2018-09-25 Herabstufung Raymond James Strong Buy → Outperform
2018-03-09 Bestätigt B. Riley FBR, Inc. Buy
2017-12-01 Fortgesetzt B. Riley FBR, Inc. Buy
2017-11-14 Fortgesetzt H.C. Wainwright Buy
2017-04-25 Eingeleitet Jefferies Buy
2017-03-06 Bestätigt FBR & Co. Outperform
2016-10-06 Fortgesetzt Brean Capital Buy
2016-05-27 Eingeleitet SunTrust Buy
2015-12-01 Eingeleitet FBR Capital Outperform
2015-09-09 Eingeleitet Raymond James Strong Buy
2015-08-12 Fortgesetzt H.C. Wainwright Buy
2015-06-19 Bestätigt Brean Capital Buy
2014-12-11 Bestätigt ROTH Capital Buy
2014-12-10 Bestätigt ROTH Capital Buy
Alle ansehen

Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten

pulisher
Jun 13, 2025

TG Therapeutics shareholders approve key proposals By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

TG Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

TG Therapeutics shareholders approve key proposals - Investing.com

Jun 13, 2025
pulisher
Jun 10, 2025

TG Therapeutics at Goldman Sachs Conference: Strategic Growth and Innovations - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : TG Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - marketscreener.com

Jun 10, 2025
pulisher
Jun 09, 2025

GAMMA Investing LLC Purchases 176,573 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire

Jun 06, 2025
pulisher
Jun 06, 2025

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference | TGTX Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

TG Therapeutics (NasdaqCM:TGTX) Stock Rises 13% In Last Month - Yahoo

Jun 06, 2025
pulisher
Jun 06, 2025

Kalkine: TG Therapeutics Schedules Fireside Chat at Goldman Sachs Conference Amid FT100 Futures Focus - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

TG Therapeutics CEO Fireside Chat at Goldman's Premier Healthcare Conference: Key Updates Coming - Stock Titan

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Sells 214,800 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

LAWSUITS FILED AGAINST U, TGTX and CVNAJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Transcript : TG Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 12 - marketscreener.com

Jun 05, 2025
pulisher
Jun 04, 2025

(TGTX) Investment Analysis and Advice - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

Jun 03, 2025
pulisher
Jun 02, 2025

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

TG Therapeutics CEO Fireside Chat: Key Updates Expected at Major Healthcare Conference - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

TG Therapeutics shares MS drug trial updates By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Mult - GuruFocus

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics shares MS drug trial updates - Investing.com

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - The Manila Times

May 30, 2025
pulisher
May 30, 2025

TG Therapeutics Announces Data Presentations for BRIUMVI in - GlobeNewswire

May 30, 2025
pulisher
May 28, 2025

TG Therapeutics: Estimates Could Soon Be Raised Again (NASDAQ:TGTX) - Seeking Alpha

May 28, 2025
pulisher
May 28, 2025

Man Group plc Purchases Shares of 9,589 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

May 28, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - The Manila Times

May 27, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at ... - Eagle-Tribune

May 27, 2025
pulisher
May 27, 2025

Bank of America Corp DE Has $6.95 Million Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

May 27, 2025
pulisher
May 25, 2025

How To Trade (TGTX) - news.stocktradersdaily.com

May 25, 2025
pulisher
May 22, 2025

Captrust Financial Advisors Sells 22,765 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

May 22, 2025
pulisher
May 21, 2025

Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance

May 21, 2025
pulisher
May 19, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

May 19, 2025
pulisher
May 18, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by BNP Paribas Financial Markets - Defense World

May 18, 2025
pulisher
May 16, 2025

TG Therapeutics' (NASDAQ:TGTX) Weak Earnings May Only Reveal A Part Of The Whole Picture - simplywall.st

May 16, 2025
pulisher
May 16, 2025

Investor Calendar Invites You to the TG Therapeutics, Inc. Third Quarter 2016 Earnings Conference Call and Webcast Live on Monday, November 7, 2016 - ACCESS Newswire

May 16, 2025
pulisher
May 15, 2025

(TGTX) Long Term Investment Analysis - news.stocktradersdaily.com

May 15, 2025
pulisher
May 13, 2025

TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN

May 13, 2025
pulisher
May 10, 2025

Decoding TG Therapeutics Inc (TGTX): A Strategic SWOT Insight - GuruFocus

May 10, 2025
pulisher
May 09, 2025

TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN

May 08, 2025
pulisher
May 07, 2025

TG Therapeutics stock sinks on profit miss - MSN

May 07, 2025
pulisher
May 07, 2025

TG Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 07, 2025
pulisher
May 06, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Str - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Jefferies maintains Buy on TGTX stock with $46 target By Investing.com - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - Yahoo Finance

May 06, 2025

Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$98.73
price up icon 1.91%
$22.82
price down icon 1.17%
$34.84
price down icon 1.22%
$19.78
price down icon 1.88%
$106.57
price up icon 1.57%
biotechnology ONC
$269.63
price down icon 2.50%
Kapitalisierung:     |  Volumen (24h):